Made with ❤️ by True Sparrow

Bringing you the latest funding data

Neurescue

Last funding round

Raised
$7,200,000
Round
Series A

Funding News (2)

Feb 5 2024Silicon Canals

Startup details

Neurescue

Neurescue

Neurescue is a medical device startup specializing in cardiovascular solutions, particularly the world’s first computer-aided balloon catheter for aortic occlusion. The company aims to enhance blood flow to the brain and heart, increasing resuscitation rates and providing additional treatment time.
www.neurescue.com
Copenhagen, Denmark
Established in 2014
11-50 People
Healthcare, Medical Devices

Founders

Dr. Habib Frost

Dr. Habib Frost

Medical Doctor, CEO

København, Hovedstaden, Denmark

Investment details

Raised
$7,200,000
Round
Series A
Investors
West Hill Capital
LEAD

Funding News (1)

Feb 5 2024FoundersToday

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from Denmark

Jun2024
1

1 week ago

Light raised a $13M Seed led by Atomico
Copenhagen-based Light reimagines general ledger software with AI for global companies.
Light

Founders

Filip Kozjak,

Jonathan Sanders

In News

TechCrunch
2

1 week ago

EvodiaBio raised $7.6M led by The March Group and 2 others
Denmark-based EvodiaBio applies precision fermentation technology to produce sustainable aromas for the F&B industry.
EvodiaBio

Founders

Simon Dusséaux,

Camilla Fenneberg,

Jarne Elleholm

In News

FoodBev Media
Tech Funding News
vegconomist - the vegan business magazine
3

2 weeks ago

GetWhy raised a $34.2M Series A from PeakSpan Capital
Copenhagen-based GetWhy provides AI-enabled consumer insights for brands, disrupting consumer research with its proprietary platform.
GetWhy

Founders

Casper Henningsen,

Jonas Alexandersson

In News

EU-Startups
TechCrunch
4

3 weeks ago

ZTLment raised a $2.6M Pre-Seed from Giant Ventures and 3 others
Copenhagen-based ZTLment revolutionizes European payments with compliant wallet infrastructure.
ZTLment

Founders

Mads Stolberg-Mathieu

In News

FinTech Global
5

3 weeks ago

Adcendo raised $17.2M led by Dawn Biopharma
Denmark-based Adcendo develops antibody-drug conjugates (ADCs) for cancer treatment.
Adcendo

Founders

Michael Pehl

In News

FinSMEs
Investors in Healthcare
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.